Two-Year Follow-up Study on Children Exposed to Trauma (Complex PTSD)
Aperçu de l'étude
Statut
Description détaillée
This study will be conducted under the coordination of Istanbul Faculty of Medicine, Department of Child and Adolescent Psychiatry. Children and adolescents between the ages of 7-18 who have been exposed to trauma and who applied to the Child and Adolescent Psychiatry outpatient clinic of Istanbul Faculty of Medicine and who were evaluated within the scope of the thesis study two year ago (January-April 2024) and one year ago (January-June 2025), will be re-evaluated two year later. It is aimed to reach all 136 children and adolescents and evaluate those who agree to participate in the study.
Sample:
Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study two year ago (January-April 2024) and re-evaluated by a doctor a year ago; Children and adolescents aged 7-18, Children and/or parents with adequate literacy and Turkish language skills, Those without psychotic/manic symptoms or a diagnosis of autism spectrum disorder or intellectual disability in the child or parent during the interview, Volunteers who agree to participate in the study. Researchers will explain the study to volunteer children and their families and present the Informed Consent Form to determine their willingness to participate.
Parents of eligible volunteers will complete the following assessments:
- Sociodemographic Data Form
- Brief Psychological Resilience Scale
- Pittsburgh Sleep Quality Index
- Mood Disorders and Schizophrenia Interview Schedule for School-Aged Children (MAS-S)
- International Trauma Scale - Child and Adolescent Version
- Children's Anxiety and Depression Scale - Revised
- UCLA Post-Traumatic Stress Disorder Reaction Index for DSM-5
- Children's General Assessment Scale
- ICD-11-based clinical interview
The start date for the study is March 2026, and data analysis will commence afterward. Data will be analyzed using the Statistical Program for Social Sciences (SPSS for Windows, version 21.0). The study is expected to be completed by October 2026
The coordinating center responsible for the research is the Department of Child and Adolescent Psychiatry at Istanbul Faculty of Medicine.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Fatih
-
Istanbul, Fatih, Turquie (Türkiye), 34116
- İstanbul Esnaf Hastanesi
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study two year ago (January-April 2024), and one year ago (January-June 2025), Children and adolescents aged 7-18, Children and/or parents with adequate literacy and Turkish language skills.
Exclusion Criteria:
- The presence of psychotic/manic symptoms in the child or parent during the interview or any condition that makes the interview and assessment impossible (e.g., mental or developmental condition or a different communication language), The child or parent refusing to participate in the study, The presence of autism spectrum disorder or intellectual disability at a severity that prevents assessment.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
children who had at least one trauma two years ago
Inclusion Criteria: Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study two year ago (January-April 2024), and one year ago (January-June 2025), Children and adolescents aged 7-18, Children and/or parents with adequate literacy and Turkish language skills. Exclusion Criteria: The presence of psychotic/manic symptoms in the child or parent during the interview or any condition that makes the interview and assessment impossible (e.g., mental or developmental condition or a different communication language), The child or parent refusing to participate in the study, The presence of autism spectrum disorder or intellectual disability at a severity that prevents assessment. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Prevalence of PTSD and Complex PTSD in Children and Adolescents Exposed to Trauma
Délai: from january 2024 to august 2026
|
This study, as part of thesis research, aims to investigate the prevalence of PTSD and CPTSD diagnoses two years after the initial evaluation in trauma-exposed children and adolescents evaluated in our outpatient clinic between January-April 2024 and January-June 2025.
|
from january 2024 to august 2026
|
|
Factors Associated with the Diagnosis of PTSD and Complex PTSD
Délai: from march 2026 to august 2026
|
We aim to investigate the correlations between PTSD, CPTSD diagnoses and various clinical measures, such as the child's PTSD symptom severity assessed by the UCLA RI-5, psychological resilience, sleep routines, and anxiety/depression severity
|
from march 2026 to august 2026
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Publications générales
- Orengul AC, Kucukardali RS, Karal BN, Gormez V. Psychometric Assessment of the UCLA PTSD Reaction Index for DSM-5 Brief Form in a Clinical Sample of Turkish Youth. Child Psychiatry Hum Dev. 2025 Aug 13. doi: 10.1007/s10578-025-01905-4. Online ahead of print.
- Kucukardali RS, Karal BN, Steinberg AM, Orengul AC. Psychometric evaluation of the UCLA PTSD Reaction Index (PTSD RI-5) in a Turkish Clinical sample of trauma-exposed children. Eur J Psychotraumatol. 2025 Dec;16(1):2465082. doi: 10.1080/20008066.2025.2465082. Epub 2025 Feb 24.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2026/470
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .